Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bilal Omer

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cytotherapy|May 31, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumorsAnne Miller, Rachel Daum, Tao Wang, et al.
Pediatric Blood & Cancer|January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid TumorsAaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Journal for Immunotherapy of Cancer|March 4, 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational applicationJiali Sun, Leslie E Huye, Natalia Lapteva, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.
Blood|February 8, 2022
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALLSwati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T CellsNatalia Lapteva, Margaret Gilbert, Iulia Diaconu, et al.
Blood Advances|December 1, 2022
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survivalCaridad Martinez, Paibel Aguayo-Hiraldo, Natalia Chaimowitz, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cytotherapy|May 31, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumorsAnne Miller, Rachel Daum, Tao Wang, et al.
Pediatric Blood & Cancer|January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid TumorsAaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Journal for Immunotherapy of Cancer|March 4, 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational applicationJiali Sun, Leslie E Huye, Natalia Lapteva, et al.
Transplantation and Cellular Therapy|June 10, 2026
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective AnalysisAlexandre Chevalier, Baptiste Bonneau, Lea Grote-Levi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2017
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell TransplantationIfigeneia Tzannou, Anastasia Papadopoulou, Swati Naik, et al.
Blood|February 8, 2022
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALLSwati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, et al.
Blood|March 24, 2022
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECsDavid H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T CellsNatalia Lapteva, Margaret Gilbert, Iulia Diaconu, et al.
Blood Advances|December 1, 2022
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survivalCaridad Martinez, Paibel Aguayo-Hiraldo, Natalia Chaimowitz, et al.
Pageof 4